Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

symbols : NVO    save search

Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
ICLR | News | $219.14 -0.79% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 0.96% C: -0.24%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.98% H: 0.66% C: -0.87%

trials research technology
Valued to be $3.4 Billion by 2026, Critical Care Therapeutics Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
BMY | $78.7 -1.6% 0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 1.72% C: 0.95%
BAX | $65.25 -2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 4.39% H: 0.97% C: -0.09%
BMRN | $83.23 -2.19% -0.29% | twitter stocktwits trandingview |
Health Technology
| | O: 1.23% H: 0.57% C: -1.48%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.0% C: 0.0%
KMDA | $4.54 0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -1.52% H: 0.67% C: -0.88%
ABEO | $0.19 3.77% 1.04% | twitter stocktwits trandingview |
Health Technology
| | O: -5.43% H: 9.2% C: 5.23%

care for therapeutics growth
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
JNJ | News | $176.94 -2.84% 0.18% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.94% C: 0.26%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.0% C: 0.0%
CCXI | $25.08 -3.54% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -4.88% H: 1.04% C: -1.25%
AZN | $65.94 -0.86% 0.21% | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.22% C: 0.38%
AZNCF | $127.2501 | twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 4.43% C: 0.03%
NVS | $84.17 -1.3% 0.17% | twitter stocktwits trandingview |
Health Technology
| | O: 1.86% H: 1.05% C: 0.24%
PFE | News | $50.66 -2.35% 0.4% | twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 1.45% C: 0.78%

disease for therapy growth
Innate Pharma to Participate in Upcoming Investor Conference - June 23, 2022
Published: 2022-06-23 (Crawled : 07:00) - biospace.com/
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.85% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 1.34% C: 1.31%
IPHA | $2.74 1.83% | twitter stocktwits trandingview |
Health Technology
| | O: -1.85% H: 3.02% C: -1.13%

pharma conference
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Published: 2022-06-22 (Crawled : 11:00) - biospace.com/
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -0.68% H: 0.0% C: 0.0%

partnership nash
Insulin Market to Exceed US$ 30 Bn by 2031; Global Burden of Diabetes and Complications Propelling Adoption of Therapies, Observes TMR Report
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BDX A | $244.53 -2.23% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

report diabetes insulin market
Global Therapeutic Proteins Market Report 2022-2031 Featuring Major Players - Abbott Laboratories; Amgen Inc.; Baxter International Inc.; Eli Lilly and Company; F.Hoffmann-La Roche
Published: 2022-06-20 (Crawled : 15:00) - prnewswire.com
BIIB | $202.53 -5.17% -0.82% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABT | News | $106.97 -1.93% -0.11% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
AMGN | $243.6 -0.51% 0.47% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
JNJ | News | $176.94 -2.84% 0.18% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BAX | $65.25 -2.19% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

report roche international market
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-20 (Crawled : 13:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

repurchase
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-13 (Crawled : 13:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -1.92% H: 0.28% C: -1.19%

repurchase
Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency
Published: 2022-06-12 (Crawled : 20:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

sogroya treatment children potential living growth hormone
At 11% CAGR, Global Peptide Therapeutics Market Size is Expected to Reach USD 74 Bn by 2028 Says Zion Market Research - Industry Trends, Share, Value, Analysis & Forecast Report
Published: 2022-06-10 (Crawled : 15:20) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -3.19% H: 0.0% C: 0.0%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -1.6% H: 0.0% C: 0.0%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: -1.09% H: 0.0% C: 0.0%
GSK | $43.35 -0.8% 0.19% | twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 0.0% C: 0.0%
GLAXF | $21.99 | twitter stocktwits trandingview |
Health Technology
| | O: 2.27% H: 0.0% C: -0.8%

research report expected therapeutics market
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-07 (Crawled : 18:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 1.85% H: 1.51% C: 1.44%

repurchase
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHA | $2.74 1.83% | twitter stocktwits trandingview |
Health Technology
| | O: 2.96% H: 0.98% C: -1.15%
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 0.0% C: 0.0%
AZN | $65.94 -0.86% 0.21% | twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.82% C: -0.64%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 0.63% C: 0.16%
IPHYF | $2.6 | twitter stocktwits trandingview |
Health Technology
| | O: 1.65% H: 0.0% C: -0.32%
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| | O: -0.94% H: 0.0% C: 0.0%

iph5201 pharma cancer
Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1
Published: 2022-06-03 (Crawled : 08:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 0.63% C: 0.16%

trials glargine insulin
Terns Pharmaceuticals Appoints Kerry Russell as Chief Medical Officer
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.22% C: -0.42%


Novo Nordisk A/S – Share repurchase programme
Published: 2022-05-30 (Crawled : 12:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

repurchase
Growth Hormone Market worth USD 5.5 Billion by 2030, Says Global Market Insights Inc.
Published: 2022-05-18 (Crawled : 11:00) - prnewswire.com
NVS | $84.17 -1.3% 0.17% | twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 0.53% C: -0.19%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.16% H: 0.43% C: -1.08%

growth market hormone
Novo Nordisk A/S: Share repurchase programme
Published: 2022-05-16 (Crawled : 14:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.14% H: 1.02% C: 0.02%

repurchase
Novo Holdings Portfolio Company F2G enters strategic collaboration with Shionogi to commercialise its new antifungal agent Olorofim in Europe and Asia
Published: 2022-05-16 (Crawled : 08:00) - prnewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.14% H: 1.02% C: 0.02%

europe collaboration
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2022-05-11 (Crawled : 14:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.55% H: 2.32% C: -0.85%


Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
ACN | News | $283.8 -3.01% 0.07% | twitter stocktwits trandingview |
Technology Services

BTG | News | $3.56 -2.73% 0.84% | twitter stocktwits trandingview |
Non-Energy Minerals

DELL | News | $48.94 -2.59% 0.0% | twitter stocktwits trandingview |
Electronic Technology

DKILF | News | $166.37 | twitter stocktwits trandingview |
Producer Manufacturing

DKILY | News | $16.05 | twitter stocktwits trandingview |
Manufacturing

GBERF | News | $546.0 | twitter stocktwits trandingview |
Producer Manufacturing

GBERY | News | $49.49 | twitter stocktwits trandingview |
Manufacturing

GLPI | News 0 d | $46.68 -0.09% 0.0% | twitter stocktwits trandingview |
Finance

INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology

JCI | News | $48.44 -0.43% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

JTEKF | News | $ 0% | twitter stocktwits trandingview |
Producer Manufacturing

JTEKY | News | $24.29 | twitter stocktwits trandingview |
Manufacturing

LEA | News | $134.75 0.57% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

LLY | News 4 | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology

NDAQ | News 4 | $154.64 -2.08% -0.23% | twitter stocktwits trandingview |
Finance

PCRFF | News | $8.15 | twitter stocktwits trandingview |
n/a

PCRFY | News | $8.22 | twitter stocktwits trandingview |
n/a

PPRUF | News | $534.0 | twitter stocktwits trandingview |
Consumer Non-Durables

PPRUY | News | $52.24 | twitter stocktwits trandingview |
Manufacturing

TMO | News | $535.77 -1.45% -0.09% | twitter stocktwits trandingview |
Health Technology